Clinical trial

Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.

NCT04674163

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2023-01-01

PhaseNA

Study timeline

Study start (estimated)2023-01-01Date precision: month

Registry last updated2023-01-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Sclerosis, Multipleunresolved

Guillain-Barre Syndromeunresolved

Inflammationunresolved

Interventions

Blood sample and Cerebrospinal fluid (CSF) collection.BIOLOGICAL

Sponsors & collaborators

Centre Hospitalier Régional d'Orléanslead sponsor

Immunologie et Neurogénétique Expérimentales et Moléculaires (INEM)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04674163 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.